| Adult Acute Promyelocytic Leukemia studied in …STUDIED_INderived28 of 28show fewer |
|---|
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897490recruiting RWE of 1st Line Treatment With ATO/ATRA for Adult APL · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005277completed Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia · condition mapped ALIAS · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664897Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105001Phase 2 · completed Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548911Phase 2 · withdrawn Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602225Phase 1/Phase 2 · completed Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869803approved for marketing Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254578Phase 1 · completed Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers · condition mapped ALIAS · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465386Phase 2 · terminated Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313586Phase 2 · completed Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ALIAS · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062075Phase 2 · completed Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588809Phase 2 · completed Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01146223completed Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00351975Phase 1 · completed Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases · condition mapped ALIAS · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132586Phase 1 · completed Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305773Phase 2 · completed Vorinostat in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301938Phase 1 · completed 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331513Phase 1 · completed Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003934Phase 3 · completed Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357305Phase 1 · completed Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005064Phase 1 · completed PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006213Phase 1 · completed BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098826Phase 1 · completed SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177371Phase 2 · completed High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (1 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |